Contact Us

Guidant Defibrillators
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Which Guidant cardiac defibrillator was implanted?

If other, what is the name of the defibrillator that was implanted?

Date the device was implanted:

Is the device still implanted?

What medical condition prompted the use of the device?

Please describe any problems or injuries caused by the product:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.


Feb 26, 2006 | May 25, 2005: Guidant Corp. reports 26 cases of failure, including the death of a young Minnesotan — from its Ventak Prizm 2 DR Model 1861 implantable defibrillator. The advisory coincides with a New York Times article saying the company waited years to warn physicians about problems with Guidant defibrillators.

June 17: Guidant voluntarily issues a worldwide safety advisory for seven types of defibrillators.

June 24: Guidant issues a second worldwide safety advisory, warning doctors to discontinue use of five models of defibrillators.

July 1: The Food and Drug Administration classifies Guidant's safety advisories as recalls.

July 18: Guidant warns doctors that nine pacemaker models made between 1997 and 2000 may need to be replaced.

July 22: Guidant says a programming change it had recommended to fix flaws in some defibrillators actually increased the chances of malfunctions in three models.

Aug. 1: The FDA approves the relaunch of Guidant's top-selling defibrillator, the Contak Renewal 3.

Sept. 22: Guidant issues recalls or safety advisories for nearly 170,000 of its top-selling Insignia and Nexus pacemakers. It notifies doctors the failure rate for two defibrillators — the Contak Renewal and Contak Renewal 2 — was nearly triple what it had earlier estimated.

Sept. 29: Citing sources it did not name, the New York Times reports the FDA has started a criminal investigation of Guidant.

Oct. 25: U.S. attorney's offices in Boston and Minneapolis issue subpoenas to Guidant, Fridley-based Medtronic and Little Canada-based St. Jude Medical for an inquiry into possible violations of "anti-kickback" and "false claims" statutes and whether doctors and clinics received inducements to use the devices.

Nov. 3: New York Attorney General Eliot Spitzer sues Guidant, alleging the company concealed information about a design flaw in a defibrillator.

Jan. 24, 2006: The U.S. attorney's office in Minneapolis subpoenas Guidant for records disclosed in a Texas lawsuit that indicate the company knew that some heart devices could catastrophically fail.

Feb. 23: FDA inspectors cite Guidant's Arden Hills plant for failing to correct quality problems and belatedly notifying regulators about a design change in implantable defibrillators.

Other articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo